| Entry |
|
|---|
| Name |
Indenolol (INN)
|
|---|
| Formula |
C15H21NO2
|
|---|
| Exact mass |
247.1572
|
|---|
| Mol weight |
247.3327
|
|---|
| Structure |
     |
|---|
| Activity |
beta-Adrenergic blocking
|
|---|
| Target |
beta1-adrenergic receptor antagonist [HSA: 153] [KO: K04141]; beta2-adrenergic receptor antagonist [HSA: 154] [KO: K04142] |
|---|
| Pathway |
hsa04020 Calcium signaling pathway
hsa04080 Neuroactive ligand-receptor interaction | |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Indenolol
D08078 Indenolol (INN)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Indenolol
D08078 Indenolol (INN)
 |
|---|
| Other DBs |
CAS: 60607-68-3 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 18
1 C8x C 22.6152 -19.6845
2 C8y C 22.6152 -21.0797
3 C8y C 23.8710 -21.7774
4 C8y C 25.0570 -21.0797
5 C8x C 25.0570 -19.6845
6 C8x C 23.8710 -18.9868
7 C1x C 21.6386 -22.0564
8 C2x C 22.1967 -23.3122
9 C2x C 23.5919 -23.1726
10 O2a O 26.2430 -21.7774
11 C1b C 27.4987 -21.0797
12 C1c C 28.6847 -21.7774
13 C1b C 29.9404 -21.0797
14 N1b N 31.1264 -21.7774
15 O1a O 28.6847 -23.1726
16 C1c C 32.3124 -21.0797
17 C1a C 33.5681 -21.7774
18 C1a C 32.3124 -19.6845
BOND 19
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 2
10 3 9 1
11 4 10 1
12 10 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 12 15 1
17 14 16 1
18 16 17 1
19 16 18 1
|
|---|
